Skip to main content
Log in

Mechanisms of Tumor-Induced Immunosuppression: Evidence for Contact-Dependent T Cell Suppression by Monocytes

  • Original Articles
  • Published:
Molecular Medicine Aims and scope Submit manuscript

Abstract

Background

The progressive growth of tumors in mice is accompanied by down-regulation of specific T cell responses. The factors involved in this suppression are not completely understood. Here, we have developed a model to examine the role of host immune effector cells in the inhibition of T cell function. In this model, progressive growth of a colon carcinoma line, CT26, is accompanied by loss of T cell response to alloantigens in both cytolytic and proliferation assays.

Materials and Methods

The CT26 tumor was inoculated into BALB/c syngeneic mice. Tumor growth, cytolytic T cell responses, lymphocyte proliferation, and flow cytometric analysis was performed in tumor-bearing animals 7 or 28 days after tumor inoculation.

Results

Spleen cells from tumor-bearing mice were found to suppress the proliferative response of spleen cells from normal mice to alloantigens. Examination of the spleen cell population by FACS analysis revealed an increase in the percentage of monocytes as defined by expression of CD1 1b, the Mac-1 antigen. Removal of the Mac-1-positive cells from the tumor-bearing hosts spleen relieved suppression of the tumor-bearing mouse spleen cell proliferative response to alloantigens, and addition of the Mac-1-positive enriched cells suppressed proliferation of normal T cells in response to alloantigens. Cell contact was required for this inhibition.

Conclusions

Tumor induction of suppressive monocytes plays an important role in the general immunosuppression noted in animals bearing CT26 tumors. Identification of the mechanisms responsible for this effect and reversal of tumor-induced macrophage suppression may facilitate efforts to develop effective immunotherapy for malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Broder S, Waldmann TA. (1978) The suppressor network in cancer. N. Engl. J. Med. 299: 1281–1284.

    Article  CAS  Google Scholar 

  2. Deckers PJ, Davis RC, Parker GA, Mannick JA. (1973) The effect of tumor size on concomitant tumor immunity. Cancer Res. 33: 139.

    Google Scholar 

  3. Maccubbin DL, Mace KF, Ehrke MJ, Mihich E. (1989) Modification of host antitumor defense mechanisms in mice by progressively growing tumor. Cancer Res. 49: 4216–4224.

    CAS  PubMed  Google Scholar 

  4. North RJ, Bursuker I. (1984) Generation and decay of the immune response to a progressive fibrosarcoma. J. Exp. Med. 159: 1312–1321.

    Article  Google Scholar 

  5. Janeway CA, Golstein P. (1993) Lymphocyte activation and effector functions. Curr. Opin. Immunol. 5: 313–323.

    Article  CAS  Google Scholar 

  6. Weiss A. (1993) T cell antigen receptor signal transduction: A tale of tails and cytoplasmic protein-tyrosine kinases. Cell 73: 209–212.

    Article  CAS  Google Scholar 

  7. Weiss A, Littman DR. (1994) Signal transduction by lymphocyte antigen receptors. Cell 76: 263–274.

    Article  CAS  Google Scholar 

  8. Tada T, Ohzeki S, Utsumi K, et al. (1991) Transforming growth factor-β-induced inhibition of T cell function. J. Immunol. 146: 1077–1082.

    CAS  PubMed  Google Scholar 

  9. Young RM, Wright MA, Coogan M, Young ME, Bagash J. (1992) Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor β. Cancer Immunol. Immunother. 35: 14–18.

    Article  CAS  Google Scholar 

  10. Malick AP, Garner R, Black SP, Elgert KD. (1984) Normal and tumor-bearing host macrophage factor-mediated modulation of mixed-lymphocyte reaction responsiveness: Separation of T-lymphocyte subset susceptibility to enhancing and inhibitory factors. Cell. Immunol. 85: 11.

    Article  Google Scholar 

  11. Walker TM, Burger CJ, Elgert KD. (1994) Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: Partial dysregulation through interleukin-10. Cell. Immunol. 154: 342–357.

    Article  CAS  Google Scholar 

  12. Fu Y, Watson G, Jimenez JJ, Wang Y, Lopez DM. (1990) Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor. Cancer Res. 50: 227–234.

    CAS  PubMed  Google Scholar 

  13. Parhar RS, Lala PK. (1988) Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages. J. Leukoc. Biol. 44: 474–484.

    Article  CAS  Google Scholar 

  14. Watson GA, Fu Y, Lopez DM. (1991) Splenic macrophages from tumor-bearing mice co-expressing MAC-1 and MAC-2 antigens exert immunoregulatory functions via two distinct mechanisms. J. Leukoc. Biol. 49: 126–138.

    Article  CAS  Google Scholar 

  15. Aoe T, Okamoto Y, Saito T. (1995) Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J. Exp. Med. 181: 1881–1886.

    Article  CAS  Google Scholar 

  16. Plautz GE, Yang Z, Wu B, Gao X, Huang L, Nabel GJ. (1993) Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc. Natl. Acad. Sci. U.S.A. 90: 4645–4649.

    Article  CAS  Google Scholar 

  17. Fernandez-Cruz E, Gilman SC, Feldman JD. (1982) Altered levels of mononuclear leukocytes in tumor-bearing rats: decrease of helper T lymphocytes and increase of suppressor cells. J. Immunol. 129: 1324–1328.

    CAS  PubMed  Google Scholar 

  18. Mizoguchi H, O’Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC. (1992) Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258: 1795–1798.

    Article  CAS  Google Scholar 

  19. Smith DR, Kunkel SL, Burdick MD, et al. (1994) Production of interleukin-10 by human bronchogenic carcinoma. Am. J. Pathol. 145: 18–25.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Howard M, O’Garra A. (1992) Biological properties of interleukin 10. Immunol. Today 13: 198–200.

    Article  CAS  Google Scholar 

  21. Ko-Huang L, Lauener RP, Winchester RJ, Geha RS, Vercelli D. (1991) Engagement of CD14 on human monocytes terminates T cell proliferation by delivering a negative signal to T cells. J. Immunol. 147: 1134–1138.

    Google Scholar 

  22. Stach RM, Rowley DA. (1993) A first or dominant immunization, II Induced immunoglobulin carries transforming growth factor β and suppresses cytolytic T cell responses to unrelated alloantigens. J. Exp. Med. 178: 841–852.

    Article  CAS  Google Scholar 

  23. Denham S, Rowland IJ. (1992) Inhibition of the reactive proliferation of lymphocytes by activated macrophages: The role of nitric oxide. Clin. Exp. Immunol. 87: 157–162.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank Donna Gschwend for secretarial assistance, Karen Carter for preparation of figures, Judy Stein for help in figure preparation and statistical analysis, and Dr. Keith Bishop for helpful advice and discussion. This work was supported in part by a grant from the National Institutes of Health (P01 CA59327-01; NIH).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jaffe, M.L., Arai, H. & Nabel, G.J. Mechanisms of Tumor-Induced Immunosuppression: Evidence for Contact-Dependent T Cell Suppression by Monocytes. Mol Med 2, 692–701 (1996). https://doi.org/10.1007/BF03401653

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03401653

Navigation